Advertisement
Optimi Health Corp.

Optimi Health Corp. Fundamental Analysis

OPTHNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$4.60
$0.56(10.85%)
U.S. Market is Open · 13:35
Advertisement

Optimi Health Corp. Fundamental Analysis

Optimi Health Corp. (OPTH) shows weak financial fundamentals with a PE ratio of -5.23, profit margin of -20.63%, and ROE of -57.27%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.08

Areas of Concern

ROE-57.27%
Operating Margin-23.00%
Cash Position3.10%
Current Ratio0.12
We analyze OPTH's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1998.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1998.0/100

We analyze OPTH's fundamental strength across five key dimensions:

Efficiency Score

Weak

OPTH struggles to generate sufficient returns from assets.

ROA > 10%
-28.16%

Valuation Score

Excellent

OPTH trades at attractive valuation levels.

PE < 25
-5.23
PEG Ratio < 2
-0.08

Growth Score

Weak

OPTH faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Weak

OPTH carries high financial risk with limited liquidity.

Debt/Equity < 1
1.33
Current Ratio > 1
0.12

Profitability Score

Weak

OPTH struggles to sustain strong margins.

ROE > 15%
-5726.65%
Net Margin ≥ 15%
-20.63%
Positive Free Cash Flow
No

Key Financial Metrics

Is OPTH Expensive or Cheap?

P/E Ratio

OPTH trades at -5.23 times earnings. This suggests potential undervaluation.

-5.23

PEG Ratio

When adjusting for growth, OPTH's PEG of -0.08 indicates potential undervaluation.

-0.08

Price to Book

The market values Optimi Health Corp. at 4.18 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.18

EV/EBITDA

Enterprise value stands at -6.44 times EBITDA. This is generally considered low.

-6.44

How Well Does OPTH Make Money?

Net Profit Margin

For every $100 in sales, Optimi Health Corp. keeps $-20.63 as profit after all expenses.

-20.63%

Operating Margin

Core operations generate -23.00 in profit for every $100 in revenue, before interest and taxes.

-23.00%

ROE

Management delivers $-57.27 in profit for every $100 of shareholder equity.

-57.27%

ROA

Optimi Health Corp. generates $-28.16 in profit for every $100 in assets, demonstrating efficient asset deployment.

-28.16%

Following the Money - Real Cash Generation

Operating Cash Flow

Optimi Health Corp. generates limited operating cash flow of $-2.95M, signaling weaker underlying cash strength.

$-2.95M

Free Cash Flow

Optimi Health Corp. generates weak or negative free cash flow of $-3.02M, restricting financial flexibility.

$-3.02M

FCF Per Share

Each share generates $-0.94 in free cash annually.

$-0.94

FCF Yield

OPTH converts -14.43% of its market value into free cash.

-14.43%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.23

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.08

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.18

vs 25 benchmark

P/S Ratio

Price to sales ratio

107.94

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.33

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.12

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.57

vs 25 benchmark

ROA

Return on assets percentage

-0.28

vs 25 benchmark

ROCE

Return on capital employed

-0.86

vs 25 benchmark

How OPTH Stacks Against Its Sector Peers

MetricOPTH ValueSector AveragePerformance
P/E Ratio-5.2334.27 Better (Cheaper)
ROE-57.27%377.00% Weak
Net Margin-2062.66%-42945.00% (disorted) Weak
Debt/Equity1.330.78 Weak (High Leverage)
Current Ratio0.125.54 Weak Liquidity
ROA-28.16%-162.00% (disorted) Weak

OPTH outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Optimi Health Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ